Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Biomea Fusion, Inc.BMEA · Entity 6606 | Director | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Biomea Fusion, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.15 · Expires 2036-06-09 | Direct | 196,299 |
Reported balance
After 2026-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 196,299 · Balance 196,299 F1: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 16:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 196,299 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001193125-26-269470 · ownership.xml · derivative · entry 1 Faust Elizabeth · CIK 0001572143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,299 Underlying: Common Stock · 196,299 shares Expires 2036-06-09 F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 16:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 91,970 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0000950170-25-086193 · ownership.xml · derivative · entry 1 Faust Elizabeth · CIK 0001572143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,970 Underlying: Common Stock · 91,970 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 16:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 51,025 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0000950170-24-073074 · ownership.xml · derivative · entry 1 Faust Elizabeth · CIK 0001572143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,025 Underlying: Common Stock · 51,025 shares Expires 2034-06-11 F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:02 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 6,989 | $0.00 Strike: $38.90 | $0.00 |
DisclosureSEC source: 0000950170-23-028671 · ownership.xml · derivative · entry 1 Faust Elizabeth · CIK 0001572143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,989 Underlying: Common Stock · 6,989 shares Expires 2033-06-13 F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 17:07 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 45,755 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0000899243-22-024051 · doc4.xml · derivative · entry 1 Faust Elizabeth · CIK 0001572143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,755 Underlying: Common Stock · 45,755 shares Expires 2032-06-21 F1 · derivative.exercise_date: The shares underlying the stock option shall vest in 36 equal monthly installments over a three year period beginning on June 22, 2022, so that all shares shall have vested on June 22, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.